Solventum Corporation $SOLV Shares Sold by Wellington Management Group LLP

Wellington Management Group LLP cut its position in shares of Solventum Corporation (NYSE:SOLV) by 71.7% during the 2nd quarter, HoldingsChannel.com reports. The firm owned 9,688 shares of the company’s stock after selling 24,604 shares during the period. Wellington Management Group LLP’s holdings in Solventum were worth $747,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also recently added to or reduced their stakes in the company. Ratan Capital Management LP acquired a new stake in shares of Solventum during the second quarter worth $1,543,000. Public Employees Retirement System of Ohio acquired a new stake in Solventum during the second quarter worth about $4,131,000. Ancora Advisors LLC acquired a new stake in Solventum during the second quarter worth about $56,000. Ally Financial Inc. bought a new position in Solventum in the second quarter worth about $964,000. Finally, Trust Co. of Vermont bought a new position in Solventum in the second quarter worth about $119,000.

Analyst Ratings Changes

Several research firms have recently commented on SOLV. Wall Street Zen raised Solventum from a “hold” rating to a “buy” rating in a report on Saturday. Weiss Ratings upgraded Solventum from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Tuesday, August 18th. UBS Group upped their price objective on Solventum from $95.00 to $101.00 and gave the stock a “buy” rating in a research note on Thursday, August 6th. BTIG Research increased their target price on Solventum from $91.00 to $95.00 and gave the stock a “buy” rating in a research report on Thursday, August 6th. Finally, Mizuho set a $113.00 target price on Solventum in a research note on Thursday, August 6th. Eight investment analysts have rated the stock with a Buy rating, three have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, Solventum currently has a consensus rating of “Moderate Buy” and a consensus price target of $92.80.

Solventum Trading Down 0.3%

Shares of SOLV stock opened at $87.43 on Friday. Solventum Corporation has a 1 year low of $62.38 and a 1 year high of $94.16. The firm has a market capitalization of $14.88 billion, a PE ratio of 10.69, a price-to-earnings-growth ratio of 1.37 and a beta of 0.61. The stock has a fifty day moving average of $85.15 and a two-hundred day moving average of $76.55. The company has a debt-to-equity ratio of 1.00, a quick ratio of 0.74 and a current ratio of 1.02.

Solventum (NYSE:SOLV) last issued its quarterly earnings results on Wednesday, August 5th. The company reported $2.55 EPS for the quarter, beating analysts’ consensus estimates of $1.91 by $0.64. Solventum had a return on equity of 25.09% and a net margin of 17.26%.The company had revenue of $2.21 billion for the quarter, compared to analyst estimates of $2.15 billion. During the same period last year, the company earned $1.69 earnings per share. The company’s quarterly revenue was up 2.2% compared to the same quarter last year. Solventum has set its FY 2026 guidance at 7.100-7.200 EPS. As a group, research analysts expect that Solventum Corporation will post 7.22 EPS for the current year.

Solventum Profile

Solventum Corporation (NYSE:SOLV) is a global healthcare company that develops products and technologies intended to improve patient care, support healthcare professionals and increase the efficiency of healthcare delivery. The company serves hospitals, clinics, dental practices, laboratories, government agencies and other healthcare-related organizations.

Its offerings include medical and surgical products such as wound-care, skin-care, infection-prevention and surgical solutions; dental products and materials; and health information systems that support clinical documentation, coding, workflow and decision-making.